Portfolio company
QV Bioelectronics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GT Medical Technologies
This company produces bioresorbable radiotherapy implants for patients with operable brain tumors to deliver targeted radiation immediately following surgical removal.
Coherence
This company develops minimally invasive implants and neurotechnology to monitor and manage cancer via real-time electrical signaling for patients with aggressive tumours.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
Salvia BioElectronics
This company develops thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraine and other neurological conditions.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
Coherence Neuro
This company develops implantable brain-computer interfaces and neurostimulation devices to monitor and treat brain cancer for patients with gliomas.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
